Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ervogastat (PF-06865571) is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor. Ervogastat reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 132.00 | |
5 mg | In stock | $ 323.00 | |
10 mg | In stock | $ 539.00 | |
25 mg | In stock | $ 869.00 | |
50 mg | In stock | $ 1,180.00 | |
100 mg | In stock | $ 1,590.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 335.00 |
Description | Ervogastat (PF-06865571) is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor. Ervogastat reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH). |
Synonyms | PF-06865571 |
Molecular Weight | 407.42 |
Formula | C21H21N5O4 |
CAS No. | 2186700-33-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120mg/ml(294.54mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ervogastat 2186700-33-2 Metabolism Transferase PF-06865571 PF06865571 PF 06865571 inhibitor inhibit